Relaxin family peptide receptor (RXFP1) coupling to Gαi3, involves the C-terminal Arg752 and localization within membrane raft microdomains

Molecular Pharmacology

Volumn 75, Issue 2, 2009, Pages 415-428

  Halls, Michelle L ^a,b   Van Der Westhuizen, Emma T ^a,b   Wade, John D ^c   Evans, Bronwyn A ^a,b   Bathgate, Ross A D ^c   Summers, Roger J ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYCLIC AMP; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE C ETA; RECEPTOR; RELAXIN; RELAXIN FAMILY PEPTIDE RECEPTOR 1; RELAXIN FAMILY PEPTIDE RECEPTOR 2; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; STRUCTURE ACTIVITY RELATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ARGININE; BINDING SITES; CELLS, CULTURED; GTP-BINDING PROTEIN ALPHA SUBUNITS, GI-GO; HUMANS; ISOENZYMES; MEMBRANE MICRODOMAINS; MEMBRANE PROTEINS; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN KINASE C-EPSILON; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, PEPTIDE; SERINE;

EID: 59449108031     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.108.051227     Document Type: Article

References (40)

1. Bahia DS, Wise A, Fanelli F, Lee M, Rees S, and Milligan G (1998) Hydrophobicity of residue 351 of the G-protein Gi1α determines the extent of activation by the α2A-adrenoceptor. Biochemistry 37:11555-11562.
2. Bartsch O, Bartlick B, and Ivell R (2001) Relaxin signallinglinks tyrosine phosphor-ylation to phosphodiesterase and adenylyl cyclase activity. Mol Hum Reprod 7:799-809.
3. Blom N, Gammeltoft S, and Brunak S (1999) Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J Mol Biol 294:1351-1362.
4. Bolard J (1986) How do the polyene macrolide antibiotics affect the cellular membrane properties? Biochim Biophys Acta 864:257-304.
5. Chun M, Liyanage UK, Lisanti MP, and Lodish HF (1994) Signal transduction of a G-protein-coupled receptor in caveolae: colocalization of endothelin and its receptor with caveolin. Proc Natl Acad Sci US A 91:11728- 11732.
6. Conrad KP and Novak J (2004) Emerging role ofrelaxin in renal and cardiovascular function. Am J Physiol Regul Integr Comp Physiol 287:R250 -R261.
7. i3 in native lung membranes. Mol Pharmacol 50:624-630.
8. Dschietzig T, Bartsch C, Stangl V, Baumann G, and Stangl K (2004) Identification of the pregnancy hormone relaxin as a glucorticoid receptor agonist. FASEB J 18:1536 -1538.
9. Halls ML, Bond CP, Sudo S, Kumagai J, Ferraro T, Layfield S, Bathgate RA, and Summers RJ (2005) Multiple binding sites revealed by interaction of relaxin family peptides with native and chimeric relaxin family peptide receptors 1 and 2 (LGR7 and LGR8). J Pharmacol Exp Ther 313:677-687.
10. Halls ML, Bathgate RA, and Summers RJ (2006) Relaxin family peptide receptors, RXFP1 and RXFP2, modulate cAMP signaling by distinct mechanisms. Mol Pharmacol 70:214-226.
11. Halls ML, Bathgate RA, and Summers RJ (2007a) Comparison of signaling pathways activated by the relaxin family peptide receptors, RXFP1 and RXFP2, using reporter genes. J Pharmacol Exp Ther 320:281-290.
12. Halls ML, van der Westhuizen ET, Bathgate RA, and Summers RJ (2007b) Relaxin family peptide receptors: former orphans reunite with their parent ligands to activate multiple signaling pathways. Br J Pharmacol 150:677-691.
13. Hisaw FL (1926) Experimental relaxation of the pubic ligament of the guinea-pig. Proc Soc Exp Biol Med 23:661-663.
14. Hsu SY (2003) New insights into the evolution ofthe relaxin-LGR signaling system. Trends Endocrinol Metab 14:303-309.
15. Hsu SY, Kudo M, Chen T, Nakabayashi K, Bhalla A, van der Spek PJ, van Duin M, and Hsueh AJ (2000) The three subfamilies of leucine-rich repeat-containing G-protein-coupled receptors (LGR): identification of LGR6 and LGR7 and the signaling mechanism for LGR7. Mol Endocrinol 14:1257-1271.
16. Hsu SY, Nakabayashi K, Nishi S, Kumagai J, Kudo M, Sherwood OD, and Hsueh AJ (2002) Activation of orphan receptors by the hormone relaxin. Science 295:671-674.
17. 3b-adrenoceptors expressed in Chinese hamster ovary cells display identical pharmacology but utilise distinct signalling pathways. Br J Pharmacol 135:1903-1914.
18. Kawamura K, Kumagai J, Sudo S, Chun SY, Pisarska M, Morita H, Toppari J, Fu P, Wade JD, Bathgate RA, et al. (2004) Paracrine regulation of mammalian oocyte maturation and male germ cell survival. Proc Natl Acad Sci U S A101:7323-7328.
19. Koch WJ, Hawes BE, Inglese J, Luttrell LM, and Lefkowitz RJ (1994) Cellular expression of the carboxyl terminus of a G-protein-coupled receptor kinase attenuates Gβγ-mediated signaling. J Biol Chem 269:6193-6197.
20. Kumagai J, Hsu SY, Matsumi H, Roh JS, Fu P, Wade JD, Bathgate RA, and Hsueh AJ (2002) INSL3/Leydig insulin-like peptide activates the LGR8 receptor important in testis descent. J Biol Chem 277:31283-31286.
21. Liu C, Eriste E, Sutton S, Chen J, Roland B, Kuei C, Farmer N, Jörnvall H, Sillard R, and Lovenberg TW (2003) Identification of relaxin-3/INSL7 as an endogenous ligand for the orphan G-protein-coupled receptor GPCR135. J Biol Chem 278: 50754-50764.
22. Liu C, Kuei C, Sutton S, Chen J, Bonaventure P, Wu J, Nepomuceno D, Kamme F, Tran DT, Zhu J, et al. (2004) INSL5 is a high affinity specific agonist for GPCR142 (GPR100). J Biol Chem 280:292-300.
23. Masuda K, Itoh H, Sakihama T, Akiyama C, Takahashi K, Fukuda R, Yokomizo T, Shimizu T, Kodama T, and Hamakubo T (2003) Acombinatorial G-protein-coupled receptor reconstitution system on budded baculovirus. J Biol Chem 278:24552-24562.
24. Menco BP, Carr VM, Ezeh PI, Liman ER, and Yankova MP (2001) Ultrastructural localisation of G-proteins and the channel protein TRP2 to microvilli of rat vomeronasal receptor cells. J Comp Neurol 438:468-489.
25. Nguyen BT, Yang L, Sanborn BM, and Dessauer CW (2003) Phosphoinositide 3-kinase activity is required for biphasic stimulation of cyclic adenosine 3′,5′- monophosphate by relaxin. Mol Endocrinol 17:1075-1084.
26. Nguyen BT and Dessauer CW (2005) Relaxin stimulates protein kinase C ζ translocation: requirement for cyclic adenosine 3′,5-monophosphate ′production. Mol Endocrinol 19:1012-1023.
27. Nguyen TD, Gow JM, Chinn LW, Kelly L, JeongH, Huang CC, Stryke D, Kawamoto M, Johns SJ, Carlson E, et al. (2006) International union of pharmacology LVII: recommendations for the nomenclature of receptors for relaxin family peptides. Pharmacol Rev 58:1-2.
28. Nistri S, Chiappini L, Sassoli C, and Bani D (2003) Relaxin inhibits lipopolysaccharide-induced adhesion of neutrophils to coronary endothelial cells by a nitric oxide-mediated mechanism. FASEB J17:2109-2111.
29. Palejwala S, Stein DE, Weiss G, Monia BP, Tortoriello D, and Goldsmith LT (2001) Relaxin positively regulates matrix metalloproteinase expression in human lower uterine segment fibroblasts using a tyrosine kinase signaling pathway. Endocrinology 142:3405-3413.
30. 2- adrenergic receptor from its partners determines signaling efficacy: insight into nanoscale organization of signal transduction. J Biol Chem 283:24659-24672.
31. Rothberg KG, Ying YS, Kamen BA, and Anderson RG (1990) Cholesterol controls the clustering of the glycophospholipid-anchored membrane receptor for 5-methyltet-rahydrofolate. J Cell Biol 111:2931-2938.
32. Sargiacomo M, Sudol M, Tang Z, and Lisanti MP (1993) Signal transducing molecules and glycosyl-phosphatidylinositol-linked proteins form a caveolin-rich insoluble complex in MDCK cells. J Cell Biol 122:789-807.
33. 3-adrenoceptor associated with differential G-protein coupling. Biochem Soc Trans 35:1035-1037.
34. Scheerer P, Park JH, Hildebrand PW, Kim YJ, Krauss N, Choe HW, Hofmann KP, and Ernst OP (2008) Crystal structure of opsin in its G-protein-interacting conformation. Nature 455:497-502.
35. Shpakov AO, Guryanov IA, Kuznetsova LA, Plesneva SA, Shpakova EA, Vlasov GP, and Pertseva MN (2006) Peptide derivatives of the LGR7 relaxin receptor control the functional activity of relaxin sensitive adenylyl cylcase. Doklady Biochem Biophys 407:109-112.
36. Sudo S, Kumagai J, Nishi S, Layfield S, Ferraro T, Bathgate RA, and Hsueh AJ (2003) H3 relaxin is a specific ligand for LGR7 and activates the receptor by interacting with both the ectodomain and the exoloop 2. J Biol Chem 278:7855-7862.
37. Tan YY, Wade JD, Tregear GW, and Summers RJ (1999) Quantitative autoradiographic studies of relaxin binding in rat atria, uterus and cerebral cortex: characterisation and effects of oestrogen treatment. Br J Pharmacol 127:91-98.
38. van der Westhuizen ET, Halls ML, Samuel CS, Bathgate RA, Unemori EN, Sutton SW, and Summers RJ (2008) Relaxin family peptide receptors - from orphans to therapeutic targets. Drug Discov Today 13:640 -651.
39. Wilkinson TN, Speed TP, Tregear GW, and Bathgate RA (2005) Evolution of the relaxin-like peptide family. BMC Evol Biol 5:14.
40. Zhang Q, Liu SH, Erikson M, Lewis M, and Unemori E (2002) Relaxin activates the MAP kinase pathway in human endometrial stromal cells. JCell Biochem 85:536-544.